SageView Advisory Group LLC Purchases Shares of 3,806 Henry Schein, Inc. (NASDAQ:HSIC)

SageView Advisory Group LLC acquired a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 3,806 shares of the company’s stock, valued at approximately $285,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Boston Partners lifted its holdings in Henry Schein by 144.1% during the 4th quarter. Boston Partners now owns 2,637,429 shares of the company’s stock valued at $199,393,000 after purchasing an additional 1,556,831 shares during the last quarter. Norges Bank bought a new position in shares of Henry Schein in the fourth quarter valued at approximately $111,715,000. Nuance Investments LLC acquired a new position in shares of Henry Schein in the 4th quarter worth approximately $103,446,000. Lazard Asset Management LLC grew its position in Henry Schein by 1,303.3% during the 3rd quarter. Lazard Asset Management LLC now owns 1,247,334 shares of the company’s stock worth $92,614,000 after acquiring an additional 1,158,451 shares during the last quarter. Finally, Fiduciary Management Inc. WI increased its holdings in Henry Schein by 17.1% during the 4th quarter. Fiduciary Management Inc. WI now owns 2,284,337 shares of the company’s stock valued at $172,947,000 after purchasing an additional 333,855 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Price Performance

HSIC opened at $66.55 on Friday. The company has a fifty day moving average price of $70.52 and a two-hundred day moving average price of $73.11. The firm has a market capitalization of $8.52 billion, a PE ratio of 22.48, a P/E/G ratio of 1.68 and a beta of 0.90. Henry Schein, Inc. has a 52 week low of $60.01 and a 52 week high of $82.63. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.02 and a current ratio of 1.75.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.09. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. During the same quarter last year, the firm earned $1.21 EPS. Henry Schein’s quarterly revenue was up 3.7% compared to the same quarter last year. As a group, analysts anticipate that Henry Schein, Inc. will post 5.17 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on HSIC shares. Evercore ISI boosted their price objective on Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research note on Wednesday, February 28th. Leerink Partnrs reissued a “market perform” rating on shares of Henry Schein in a report on Monday, February 26th. JPMorgan Chase & Co. raised their price objective on shares of Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a research report on Wednesday, March 6th. Jefferies Financial Group upped their target price on shares of Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research report on Wednesday, March 6th. Finally, Barrington Research raised their price target on shares of Henry Schein from $90.00 to $92.00 and gave the company an “outperform” rating in a report on Wednesday, May 8th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $81.73.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.